by Ethan Huff
(Health Secrets) Mass hysteria is reverberating throughout the mainstream media following a relatively minor outbreak of meningitis at Princeton University in New Jersey. As you may already know, officials at the school have responded to seven identified cases of the illness by considering a call for all students to be offered an unapproved meningitis vaccine from Europe. But here to bring reason to the situation is Dr. Sherri Tenpenny, a noted expert on vaccines, who rightly points out in a recent posting that, like most others, this latest mass vaccination campaign lacks both rational thought and scientific merit.
[Sponsor link: Vaccine and Detoxification Healing Protocol, Vaccine Report ]
While only seven students at Princeton have been diagnosed as having meningitis since March of last year, news reports are still blaring outrageous headlines claiming that an epidemic might be in the works and that this generally rare disease is somehow “sweeping” the Ivy League campus.
Truth be told, seven isolated cases of a disease that does not spread through the air or through casual contact can hardly be considered an epidemic. But using such outrageously inaccurate language sure helps convey the type of irrational urgency needed to push an unapproved “emergency” vaccine.
“The infection occurs randomly and will not spread rapidly across the campus to other students,” writes Dr. Tenpenny. She decried calls by officials from Princeton, the U.S. Centers for Disease Control and Prevention (CDC), and the U.S. Department of Health and Human Services (HHS) to rush in the Novartis vaccine Bexsero, which has never been approved by the U.S. Food and Drug Administration (FDA).
The type of meningitis that has inflicted this small handful of Princeton students, known as serotype B, just so happens to be the most common form of bacterial meningitis. But there is currently no approved vaccine for serotype B meningitis, because the cell wall of this particular bacterial strain very closely resembles that of the brain and nerves. In other words, getting vaccinated against serotype B using the traditional approach would mean risking that vaccine-induced antibodies might also attack the brain and nerves.